Olivier Lipp
Biographic Data
| ID | 5420705 |
|---|---|
| NAME | Olivier Lipp |
| GIVEN NAMES | Olivier |
| FAMILY NAME | Lipp |
| SIGNATURE | LIPP O |
| AFFILIATIONS | Université de Montréal |
| VERIFIED | No |
| TOTAL WORKS | 6 |
| TOTAL CITATIONS | 2 |
| AUTHOR COUNT | 6 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2008 |
| LATEST PUBLICATION YEAR | 2020 |
| H-INDEX | 1 |
Violent Behavior Is Associated With Emotion Salience Network Dysconnectivity in Schizophrenia
Background: Despite individuals with schizophrenia being at an elevated risk of violence compared to the general population, limited efforts have been invested in investigating the neurobiological etiology explaining the increase. Among the few studies examining functional disruptions pertaining to violent schizophrenia patients using fMRI, only one study has considered functional connectivity. The current state of knowledge does not allow to inf…
Impaired Coupling between the Dorsomedial Prefrontal Cortex and the Amygdala in Schizophrenia Smokers Viewing Anti-smoking Images
Given the well-established roles of the dmPFC in social cognition and of the AMG in emotional processing, our results suggest that the relative indifference of schizophrenia smokers regarding the negative consequences of tobacco smoking could be explained by a cognitive-affective dissonance
Plasma Endocannabinoid Alterations in Individuals with Substance Use Disorder are Dependent on the “Mirror Effect” of Schizophrenia
Schizophrenia is a complex psychiatric disorder strongly associated with substance use disorders. Theoretically, schizophrenia and SUD may share endocannabinoid alterations in the brain reward system. The main endocannabinoids, anandamide, and 2-arachidonoylglycerol, are lipids which bind cannabinoid receptors. Oleoylethanolamide (OEA), a fatty-acid ethanolamide, binds peroxisome proliferator-activated receptors. The endocannabinoid system has be…
Predictors of Community Functioning in Schizophrenia and Substance Use Disorder Patients
Evolution of Substance use, Neurological and Psychiatric Symptoms in Schizophrenia and Substance use Disorder Patients
Neurological and psychiatric symptoms are consequences of substance abuse in schizophrenia and non-schizophrenia patients. The present case-control study examined changes in substance abuse/dependence, and neurological and psychiatric symptoms in substance abusers with [dual diagnosis (DD) group, n = 26] and without schizophrenia [substance use disorder (SUD) group, n = 24] and in non-abusing schizophrenia patients (SCZ group, n = 23) undergoing …
Améliorer les symptômes et le tabagisme chez les personnes souffrant de schizophrénie
Contexte : Le tabagisme est élevé chez les personnes souffrant de schizophrénie ; certains patients réclament une aide au niveau de la médication qu’ils reçoivent afin de cesser de fumer. Objectif : Parmi les traitements pharmacologiques de la schizophrénie, la clozapine peut réduire la consommation de cigarettes. Les effets de la quétiapine, un autre antipsychotique atypique partageant plusieurs propriétés structurales et pharmacologiques avec l…
Améliorer les symptômes et le tabagisme chez les personnes souffrant de schizophrénie
Contexte : Le tabagisme est élevé chez les personnes souffrant de schizophrénie ; certains patients réclament une aide au niveau de la médication qu’ils reçoivent afin de cesser de fumer. Objectif : Parmi les traitements pharmacologiques de la schizophrénie, la clozapine peut réduire la consommation de cigarettes. Les effets de la quétiapine, un autre antipsychotique atypique partageant plusieurs propriétés structurales et pharmacologiques avec l…
Evolution of Substance use, Neurological and Psychiatric Symptoms in Schizophrenia and Substance use Disorder Patients
Neurological and psychiatric symptoms are consequences of substance abuse in schizophrenia and non-schizophrenia patients. The present case-control study examined changes in substance abuse/dependence, and neurological and psychiatric symptoms in substance abusers with [dual diagnosis (DD) group, n = 26] and without schizophrenia [substance use disorder (SUD) group, n = 24] and in non-abusing schizophrenia patients (SCZ group, n = 23) undergoing …
Plasma Endocannabinoid Alterations in Individuals with Substance Use Disorder are Dependent on the “Mirror Effect” of Schizophrenia
Schizophrenia is a complex psychiatric disorder strongly associated with substance use disorders. Theoretically, schizophrenia and SUD may share endocannabinoid alterations in the brain reward system. The main endocannabinoids, anandamide, and 2-arachidonoylglycerol, are lipids which bind cannabinoid receptors. Oleoylethanolamide (OEA), a fatty-acid ethanolamide, binds peroxisome proliferator-activated receptors. The endocannabinoid system has be…
Predictors of Community Functioning in Schizophrenia and Substance Use Disorder Patients
Impaired Coupling between the Dorsomedial Prefrontal Cortex and the Amygdala in Schizophrenia Smokers Viewing Anti-smoking Images
Given the well-established roles of the dmPFC in social cognition and of the AMG in emotional processing, our results suggest that the relative indifference of schizophrenia smokers regarding the negative consequences of tobacco smoking could be explained by a cognitive-affective dissonance
Violent Behavior Is Associated With Emotion Salience Network Dysconnectivity in Schizophrenia
Background: Despite individuals with schizophrenia being at an elevated risk of violence compared to the general population, limited efforts have been invested in investigating the neurobiological etiology explaining the increase. Among the few studies examining functional disruptions pertaining to violent schizophrenia patients using fMRI, only one study has considered functional connectivity. The current state of knowledge does not allow to inf…
Medicine (6 works) · Psychiatry (5 works) · Psychology (5 works) · Schizophrenia (object-oriented programming (5 works) · Schizophrenia research and treatment (4 works) · Cognition (3 works) · Psychosis (3 works) · Bipolar Disorder and Treatment (2 works) · Functional Brain Connectivity Studies (2 works) · Mental Health Research Topics (2 works)